Abstract
Regular universal screening for cervical cancer is associated with a considerable reduction in the disease. However, opportunistic screening has tended to reach groups at low risk and miss those at high risk from the disease. This study assessed the cost-effectiveness of a call and recall system for cervical screening which was set up in one general practice.
The practice age-sex register and records were used to monitor the screening status of women patients. Of the eligible population aged 36-60 years 70% were found to have been screened in the previous five years. The remainder were offered an appointment for a cervical smear and 57% attended following this invitation. Three smears out of 110 undertaken were reported as showing marked dyskaryosis or cervical intraepithelial neoplasia grade III. The estimated cost per case identified was £366.
A call system in general practice can increase the uptake of cervical screening among women at risk. It is a relatively cost-effective method of preventing cervical cancer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cook G. A., Draper G. J. Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer. 1984 Sep;50(3):367–375. doi: 10.1038/bjc.1984.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cullum D. E., Savory J. N. Patient preferences for cervical cytology. Br Med J (Clin Res Ed) 1983 Jul 30;287(6388):329–330. doi: 10.1136/bmj.287.6388.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Draper G. J. Screening for cervical cancer: revised policy. The recommendations of the DHSS Committee on Gynaecological Cytology. Health Trends. 1982 May;14(2):37–40. [PubMed] [Google Scholar]
- Knox E. G. Ages and frequencies for cervical cancer screening. Br J Cancer. 1976 Oct;34(4):444–452. doi: 10.1038/bjc.1976.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- La Vecchia C., Franceschi S., Decarli A., Fasoli M., Gentile A., Tognoni G. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984 Oct 6;2(8406):779–782. doi: 10.1016/s0140-6736(84)90705-0. [DOI] [PubMed] [Google Scholar]
- Roberts C. J., Farrow S. C., Charney M. C. Cost of saving a life by cervical screening. Lancet. 1985 Oct 26;2(8461):950–950. doi: 10.1016/s0140-6736(85)90882-7. [DOI] [PubMed] [Google Scholar]
- Roberts C. J., Farrow S. C., Charny M. C. How much can the NHS afford to spend to save a life or avoid a severe disability? Lancet. 1985 Jan 12;1(8420):89–91. doi: 10.1016/s0140-6736(85)91975-0. [DOI] [PubMed] [Google Scholar]
- Standing P., Mercer S. Quinquennial cervical smears: every woman's right and every general practitioner's responsibility. Br Med J (Clin Res Ed) 1984 Oct 6;289(6449):883–886. doi: 10.1136/bmj.289.6449.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sweetnam P., Evans D. M., Hibbard B. M., Jones J. M. The Cardiff Cervical Cytology Study. Prevalence and epidemiology of cervical neoplasia. J Epidemiol Community Health. 1981 Jun;35(2):83–90. doi: 10.1136/jech.35.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thorn J. B., Russell E. M., Macgregor J. E., Swanson K. Costs of detecting and treating cancer of the uterine cervix in North-East Scotland in 1971. Lancet. 1975 Mar 22;1(7908):674–676. doi: 10.1016/s0140-6736(75)91771-7. [DOI] [PubMed] [Google Scholar]